MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$25,797K
EPS
-$27.59
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
Research and development
21,226
General and administrative
4,582
Total operating expenses
25,808
Loss from operations
-25,808
Interest income
264
Interest expense
251
Change in fair value of preferred stock tranche liability
0
Total other (income) expense, net
-2
Total other (income) expense, net
11
Net loss and comprehensive loss
-25,797
Basic EPS
-27.59
Diluted EPS
-27.59
Basic Average Shares
935,000
Diluted Average Shares
935,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$264K
Net loss and
comprehensive loss
-$25,797K
Total other (income)
expense, net
$11K
Interest expense
$251K
Total other (income)
expense, net
-$2K
Loss from operations
-$25,808K
Total operating
expenses
$25,808K
Research and development
$21,226K
General and
administrative
$4,582K
Buy us a coffee
Latigo Biotherapeutics, Inc. (LTGO)
Latigo Biotherapeutics, Inc. (LTGO)